Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Finch Therapeutics Group, Inc. (FNCH) since 2021 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Finch Therapeutics Group, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1733257.
Total stock buying since 2021: $2,151,340.
Total stock sales since 2021: $28,451.
Total stock option exercises since 2021: $0.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2024 | 0 | $0 | 8,242 | $21,346 | 0 | $0 |
| 2023 | 5,010 | $1,352 | 6,089 | $7,105 | 0 | $0 |
| 2021 | 152,085 | $2,149,988 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2024-03 | 0 | $0 | 8,242 | $21,346 | 0 | $0 |
| 2023-11 | 0 | $0 | 1,470 | $5,350 | 0 | $0 |
| 2023-06 | 5,010 | $1,352 | 0 | $0 | 0 | $0 |
| 2023-02 | 0 | $0 | 4,619 | $1,755 | 0 | $0 |
| 2021-12 | 63,850 | $649,993 | 0 | $0 | 0 | $0 |
| 2021-03 | 88,235 | $1,499,995 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-03-28 | Smisek Jeffery A | Sale | 8,242 | 2.59 | 21,346 |
| 2023-11-22 | Smisek Jeffery A | Sale | 1,470 | 3.64 | 5,350 |
| 2023-06-09 | Graf Susan E (Director) | Buy | 5,010 | .27 | 1,352 |
| 2023-02-21 | Blaustein Marc (Chief Operating Officer) | Sale | 4,619 | .38 | 1,755 |
| 2021-12-20 | Haft Nicholas | Buy | 63,850 | 10.18 | 649,993 |
| 2021-03-23 | Smisek Jeffery A (Director) | Buy | 88,235 | 17.00 | 1,499,995 |
Insider trading activities including stock purchases, stock sales, and option exercises of FNCH listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Finch Therapeutics Group, Inc. (symbol FNCH, CIK number 1733257) see the Securities and Exchange Commission (SEC) website.